Related Experiment Video
Updated: May 21, 2026

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair
Published on: February 3, 2017
Optimizing cardiac repair and regeneration through activation of the endogenous cardiac stem cell compartment
Georgina M Ellison1, Bernardo Nadal-Ginard, Daniele Torella
1Stem Cell & Regenerative Biology Unit (BioStem), RISES, Liverpool John Moores University, Byrom Street, Liverpool, UK. G.M.Ellison@ljmu.ac.uk
Insights
Heart failure is rising, but the adult heart has stem cells (eCSCs) that could enable repair. Activating these endogenous cardiac stem cells offers a promising therapeutic strategy for heart regeneration.
Area of Science:
- Cardiovascular Biology
- Regenerative Medicine
Background:
- Heart failure (HF) is increasing globally due to aging populations and declining acute coronary syndrome mortality.
- Effective therapies are crucial for preventing and ameliorating HF.
- The optimal cell source for cardiac regeneration remains under investigation.
Purpose of the Study:
- To explore the potential of endogenous cardiac stem/progenitor cells (eCSCs) for cardiac regeneration.
- To discuss the implications of eCSCs for developing novel HF therapies.
Main Methods:
- Review of current understanding of adult mammalian heart biology.
- Analysis of the role of endogenous cardiac stem/progenitor cells (eCSCs) in cardiac repair.
Main Results:
- The adult mammalian heart contains multipotent cardiac stem/progenitor cells (eCSCs).
- Cardiomyocytes undergo replacement throughout adulthood, suggesting intrinsic repair capacity.
- eCSCs offer a potential mechanism for the heart's self-repair when stimulated.
Conclusions:
- Endogenous cardiac stem/progenitor cells (eCSCs) represent a paradigm shift in cardiovascular biology.
- Activating eCSCs in situ could lead to an "off-the-shelf" regenerative therapy for heart failure.
- Further understanding of eCSC biology is needed to optimize clinical applications.
Abstract:
Given the aging of the Western World and declining death rates due to acute coronary syndromes, the increasing trends in the magnitude and morbidity of heart failure (HF) are predicted to continue for the foreseeable future. It is imperative to develop effective therapies for the amelioration and prevention of HF. The search for the best cell type to be used in clinical protocols of cardiac regeneration is still on. That the adult mammalian heart harbors endogenous, multipotent cardiac stem/progenitor cells (eCSCs) and that cardiomyocytes are replaced throughout adulthood represent a paradigm shift in cardiovascular biology. The presence of eCSCs supports the view that the heart can repair itself if the eCSCs can be properly stimulated. Pending a better understanding of eCSC biology, it should be possible to replace autologous cell transplantation-based myocardial regeneration protocols with an "off-the-shelf," readily available, and effective regenerative/reparative therapy based on activation of the eCSCs in situ.
Related Concept Videos
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Tissue Renewal without Stem Cells
However, failure of such a system...

